ANIK
Anika Therapeutics Inc
Price:  
27.90 
USD
Volume:  
38,780.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika WACC - Weighted Average Cost of Capital

The WACC of Anika Therapeutics Inc (ANIK) is 5.6%.

The Cost of Equity of Anika Therapeutics Inc (ANIK) is 7.30%.
The Cost of Debt of Anika Therapeutics Inc (ANIK) is 5.00%.

Range Selected
Cost of equity 6.00% - 8.60% 7.30%
Tax rate 18.90% - 22.40% 20.65%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.0% - 6.2% 5.6%
WACC

Anika WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.46 0.66
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.00% 8.60%
Tax rate 18.90% 22.40%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.0% 6.2%
Selected WACC 5.6%